Comparison

cis-ACPD European Partner

Item no. HY-19434A-100mg
Manufacturer MedChem Express
CASRN 477331-06-9
Amount 100 mg
Category
Type Chemicals
Specific against other
Citations [1]Schoepp DD, et, al. In vitro and in vivo pharmacology of trans- and cis-(+-)-1-amino-1,3-cyclopentanedicarboxylic acid: dissociation of metabotropic and ionotropic excitatory amino acid receptor effects. J Neurochem. 1991 May; 56(5):1789-96.<br>[2]Conti P, et, al. Synthesis and pharmacology of 3-hydroxy-delta2-isoxazoline-cyclopentane analogues of glutamic acid. Farmaco. 2002 Nov; 57(11): 889-95.
Smiles O=C([C@]1(N)C[C@H](C(O)=O)CC1)O
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Available
Product Description
cis-ACPD is a potent agonist of NMDA receptor, with an IC50 of 3.3 μM. cis-ACPD is also a selective agonist of group II mGluR, with EC50s of 13 μM and 50 μM for mGluR2 and mGluR4, respectively[1][2].
Shipping
Room temperature
Manufacturers Applications
Neuroscience-Neurodegeneration
MolecularWeight
173.17
Clinical_Information
No Development Reported
Manufacturers Research_Area
Neurological Disease
Solubility
10 mM in DMSO
Manufacturers Target
iGluR; mGluR
Isoform
mGluR2; mGluR4; NMDA Receptor
Pathway
GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close